1875.HK
Price:
$2.05
Market Cap:
$1.40B
TOT BIOPHARM International Company Limited, an investment holding company, engages in the research and development, manufacture, and marketing of anti-tumor drugs in the People's Republic of China. The company's principal drug candidate is TAB008 for the treatment of non-squamous non-small-cell lung cancer metastatic colorectal cancer, glioblastoma multiforme, ovarian cancer, cervical cancer, and hepatocellular carcinoma. It also offers TOZ309 for malignant brain tumor. Further, the company develops TAA013 for HER2+ breast cancer which is under Phase III clinical trial; TAE020 which is under preclinical trial for acute myeloid leukemia; TAB014 for wet age-related macular degeneration and is ...[Read more]
Industry
Biotechnology
IPO Date
2019-11-08
Stock Exchange
HKSE
Ticker
1875.HK
According to TOT BIOPHARM International Company Limited’s latest financial reports and current stock price. The company's current ROE is 4.78%. This represents a change of -4107.01% compared to the average of -0.12% of the last 4 quarters.
The mean historical ROE of TOT BIOPHARM International Company Limited over the last ten years is -27.59%. The current 4.78% ROE has changed -117.34% with respect to the historical average. Over the past ten years (40 quarters), 1875.HK's ROE was at its highest in in the June 2024 quarter at 4.36%. The ROE was at its lowest in in the December 2021 quarter at -43.63%.
Average
-27.59%
Median
-22.79%
Minimum
-192.31%
Maximum
145.42%
Discovering the peaks and valleys of TOT BIOPHARM International Company Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 57.36%
Maximum Annual ROE = 145.42%
Minimum Annual Increase = -186.63%
Minimum Annual ROE = -192.31%
Year | ROE | Change |
---|---|---|
2024 | 4.76% | -186.63% |
2023 | -5.50% | -21.36% |
2022 | -6.99% | -91.03% |
2021 | -77.95% | 57.36% |
2020 | -49.54% | 28.39% |
2019 | -38.59% | -126.54% |
2018 | 145.42% | -175.62% |
The current ROE of TOT BIOPHARM International Company Limited (1875.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.58%
5-year avg
-27.04%
10-year avg
-27.59%
TOT BIOPHARM International Company Limited’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TOT BIOPHARM International Company Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TOT BIOPHARM International Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is TOT BIOPHARM International Company Limited's ROE?
How is the ROE calculated for TOT BIOPHARM International Company Limited (1875.HK)?
What is the highest ROE for TOT BIOPHARM International Company Limited (1875.HK)?
What is the 3-year average ROE for TOT BIOPHARM International Company Limited (1875.HK)?
What is the 5-year average ROE for TOT BIOPHARM International Company Limited (1875.HK)?
How does the current ROE for TOT BIOPHARM International Company Limited (1875.HK) compare to its historical average?